REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
13/06/2026
Voltar para busca
Dado oficial do USPTO
WE ARE BLOOD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
14/06/2026
Tipo de marca
Mista
Classes Nice
39, 44
Data de depósito
20/10/2016
Data de registro
13/06/2017
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/04/2023
Última transação
14/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
20/10/2016
Primeiro uso no comércio
20/10/2016
Código do desenho
3
Tipo de titular
54
Localização do titular
Austin, TX, US
Examinador
SIRIGNANO, EMMA MARIE
Unidade examinadora
M40
Localização atual
TMO LAW OFFICE 113
Descrição da marca
The mark consists of a stylized tree with leaves in the shape of inverted blood drops centered within a circle surrounded by a larger circle; the words "WE ARE" appear in the upper half of the outer circle and the word "BLOOD" appears in the lower half of the same circle with the upper and lower halves of the outer circle separated by horizontal lines crossed by short slightly curved vertical lines.
Titulares e representantes
Titulares
W. B. (pessoa física)
Central Texas Regional Blood and Tissue Center
Representantes
Kirby Cronin Ferguson Braswell Fraser Kubasta, PC
Classificação técnica
Classes Nice
Classe 39Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 39
supplying and distributing human blood products for othersdelivery of donated blood products to hospitals and healthcare facilities; distributing human blood products for otherstransportation of blood products for others
Classe 44
Blood bank and blood bank servicescollection and preservation of human blood and blood components; medical servicestherapeutic apheresis and transfusion procedureswhite blood cell and platelet depletiontherapeutic plasma exchangered blood cell exchange; collection and preservation of human blood; community blood supply management servicescollection and preservation of human blood and blood bank services; medical servicesprocessing of human blood and performing therapeutic apheresis on human bloodstem cell collection and related treatments; providing a website featuring information about the importance of donating blood and blood componentshow to donate blood and blood componentsthe best way for individuals to donate blood and blood components depending on their blood type; patient blood testing for cross-testing purposes; medical servicesautologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant hormone refractory prostate cancer; mobile human blood collection; apheresis automated human blood collection; medical testing of blood; infectious disease testing of blood and blood component donors; therapeutic phlebotomy services; compatibility and reference testing for patient samples of blood or blood products; collection and preservation of human bloodcollecting autologous donations; collection and preservation of human bloodmononuclear cell (MNC)granulocyteperipheral blood stem cell collections; collection and preservation of human bloodcollecting automated red cell donations; tissue baking servicesadult stem cell collections and banking service for individuals who wish to collect and store stem cells for future medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
27/04/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27/04/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/04/2023
E815
TEAS SECTION 8 & 15 RECEIVED
18/10/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/08/2017
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
31/07/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/07/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
23/06/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2017
PUBO
PUBLISHED FOR OPPOSITION
28/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/02/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/02/2017
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/02/2017
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
04/02/2017
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
04/02/2017
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
04/02/2017
DOCK
ASSIGNED TO EXAMINER
30/01/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
27/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/10/2016
NWAP
NEW APPLICATION ENTERED
24/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WE ARE BLOOD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.